Synthetic vaccine particles for durable cytolytic T lymphocyte responses and anti-tumor immunotherapy.
Ilyinskii PO, Kovalev GI, O'Neil CP, Roy CJ, Michaud AM, Drefs NM, Pechenkin MA, Fu FN, Johnston LPM, Ovchinnikov DA, Kishimoto TK.
Ilyinskii PO, et al. Among authors: kovalev gi.
PLoS One. 2018 Jun 1;13(6):e0197694. doi: 10.1371/journal.pone.0197694. eCollection 2018.
PLoS One. 2018.
PMID: 29856772
Free PMC article.